Tuesday, June 7, 2022

From R250 per month, you can start saving with a Sanlam Tax-free investment

Blu Approved: Benefit from tax savings when you invest in a Sanlam Tax-free Investment.
Can't read this email? View it here 
  Blu Approved

  From R250 per month, a Sanlam Tax-free Investment allows you to access your money at any time. Click here to request a call from a Sanlam consultant  
     
  Save for your long-term goals without having to pay tax on interest, dividends, or capital gains  
 
Good Day,

From as little as R250 per month, Sanlam Tax-free Investments provide an easy effective way to save for your long-term goals, without having to pay tax on interest, dividends or capital gains. Other features include:

1. The ability to withdraw money at any time
2. Contributions up to a maximum of R36 000 per year
3. Lifetime contribution limit of R500 000

Sanlam Tax-free Investments is an effective way to save for longer-term goals, like your child's education, as you pay no tax on investment return. Now is the time to plan.

The sooner you start, the more your savings will grow and the sooner you'll reach your goals.

Invest in the Sanlam Tax-free Investment plan
from R250 per month
and save tax-free

 
Call me back
 
 
 

Sanlam, 2 Strand Road, Bellville, South Africa
Sanlam Life Insurance is a Licensed Financial Services Provider
Copyright © 2018. All rights reserved.


This email is a direct marketing campaign powered by Blue Label Data Solutions on behalf of Sanlam. You are receiving this offer because you are a member of our customer database. If you choose to register on the Sanlam Website or Application and/or subscribe for Sanlam product and/or services, Sanlam's privacy policy and terms of service will apply and that will include consent to Sanlam sharing personal information which you give them with us for record keeping purposes, to enable us to update your personal information on our database accurately and for further marketing services.
 

Unsubscribe from these messages - click here

No comments:

Post a Comment